Navigation Links
Cardica Announces Fiscal 2013 Second Quarter Financial Results
Date:1/31/2013

s can listen to the call at www.earnings.com, Thomson's individual investor portal, powered by StreetEvents. Institutional investors can access the call via Thomson StreetEvents at www.streetevents.com, a password-protected event management site.

About Cardica Cardica designs and manufactures proprietary stapling and anastomotic devices for cardiac and laparoscopic surgical procedures. Cardica's technology portfolio is intended to minimize operating time and enable minimally-invasive and robot-assisted surgeries. Cardica manufactures and markets its automated anastomosis systems, the C-Port® Distal Anastomosis Systems and PAS-Port® Proximal Anastomosis System for coronary artery bypass graft (CABG) surgery, and has shipped over 44,100 units throughout the world. In addition, Cardica is developing the Cardica® MicroCutter XCHANGE™ 30, a cartridge-based microcutter device with a five-millimeter shaft diameter, and the Cardica® MicroCutter XPRESS™ 30, a true multi-fire laparoscopic stapling device. Both MicroCutter devices are designed to be used in a variety of procedures, including bariatric, colorectal, thoracic and general surgery. The Cardica MicroCutter XCHANGE 30 and XPRESS 30 products require 510(k) review and are not yet commercially available in the U.S. 

Forward-Looking StatementsThe statements in this press release regarding Cardica's plans to extend its commercial launch of the MicroCutter XCHANGE™ 30 gradually, and its intention to enroll additional patients in its European clinical trial using the commercial version of the XCHANGE 30 in the weeks ahead, with a planned enrollment completion in the second quarter of calendar year 2013,  are "forward-looking statements." The words "intend" and "plan" are intended to identify these forward-lookin
'/>"/>

SOURCE Cardica, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Cardica To Announce Fiscal 2013 Second Quarter Financial Results On Thursday, January 31, 2013
2. Cardica To Present At Lazard Capital Markets 9th Annual Healthcare Conference
3. Cardica Announces Fiscal 2013 First Quarter Financial Results
4. Cardica To Present At 2012 Wedbush PacGrow Life Sciences Management Access Conference
5. Cardica Announces Fiscal 2012 Fourth Quarter And Year End Financial Results
6. Cardica To Announce Fiscal 2012 Fourth Quarter And Full Year Financial Results On Thursday, August 2, 2012
7. Cardica Announces Fiscal 2012 Third Quarter Financial Results
8. Oclaro Announces Second Quarter Fiscal Year 2013 Financial Results
9. KaloBios Pharmaceuticals Announces Pricing of Initial Public Offering
10. CryoLife Announces Release Date and Teleconference Call Details for 2012 Fourth Quarter and Year End Financial Results
11. Blue Belt Technologies Announces First U.S. Sale of NavioPFS Surgical System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... 2014  Tokyo-based Atonarp Inc. announced today $8 ... by Walden Riverwood Ventures with participation from other ... Smart Spectrometer technology platform, which will enable a ... the oil & gas and healthcare industries for ... to partner with Atonarp in pursuing the commercialization ...
(Date:8/19/2014)... 2014  Boehringer Ingelheim today announced that the ... review the New Drug Application (NDA) for the ... via the Respimat ® inhaler for the ... airflow obstruction in patients with chronic obstructive pulmonary ... + olodaterol FDC will not be indicated to ...
(Date:8/19/2014)...  Cardiva Medical, Inc. announced today that it has ... Series 3 private equity financing and a $12.5 million ... use the proceeds of the Series 3 private equity ... its VASCADE® Vascular Closure System in the ... Series 3 private equity financing was a new investor, ...
Breaking Medicine Technology:Atonarp Inc. Raises $8M Series A Round Led by Walden Riverwood Ventures 2Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 2Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 3Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 4Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 5Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 6Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 7Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 8Cardiva Medical, Inc. Announces Completion of the first two tranches of Series 3 Private Equity Financing and the Closing of a Senior Secured Debt Facility with GE Capital 2
... a just-released National Minority Quality Forum Issue Brief ... Gary Puckrein and Gretchen Wartman examine specialty ... and private) as a benefit-management tool to limit their ... certain high-cost prescription drugs. The authors remind us that, ...
... cable network dedicated to serving the needs of Generation 50+, will ... You: Your Questions, Your Choices on August 15 at ... will turn 65 and become eligible for Medicare every day for ... Signing up for Medicare means making choices, and for many, the ...
Cached Medicine Technology:Prescription-Drug Plans' Use of Specialty Tiers Promotes Inequalities 2Making Medicare Work for You: Your Questions, Your Choices 2Making Medicare Work for You: Your Questions, Your Choices 3
(Date:8/20/2014)... The Workgroup for Electronic Data ... the use of health IT to create efficiencies ... for its annual fall conference, WEDI-Con 2014: The ... will take place at the HYATT Regency in ... diverse cross-section of payers, providers, government regulators, industry ...
(Date:8/20/2014)... Fresh from the cradle of a world-class running city, an ... , Urbini, a new collection of versatile baby gear from ... jogger to its lineup. , The Avi has been in ... the latest racing styles and a set of features to ... a swift, smooth ride on runs, power-walks and causal strolls. ...
(Date:8/20/2014)... (PRWEB) August 20, 2014 If old age ... a cure for it. With extensive research on HGH and ... ‘MetroMD’ claims to have perfected the art of rubbing off ... brand new younger look with their revolutionary anti-aging hormone therapy ... the 21st century fountain of youth, the MD of MetroMD, ...
(Date:8/20/2014)... NC (PRWEB) August 20, 2014 Doctors at ... way to wipe out mesothelioma in laboratory mice by injecting ... has just posted details of the study on its website. ... , Scientists with Hong Kong University’s AIDS Institute of Microbiology ... protein 1” or PD-1. By altering DNA, the vaccine is ...
(Date:8/20/2014)... (PRWEB) August 20, 2014 The ... a five-year, $1.24 million Science Education Partnership Award ... to support NAHN’s collaborative project with the Hispanic ... Health Careers. , This collaborative NIH R25 program ... cultural and linguistic diversity among health professionals by ...
Breaking Medicine News(10 mins):Health News:WEDI Releases Full Conference Agenda for Its Annual Fall Conference – WEDI-Con 2014 2Health News:WEDI Releases Full Conference Agenda for Its Annual Fall Conference – WEDI-Con 2014 3Health News:Urbini Breezes Through Summer with New Jogging Stroller 2Health News:MetroMD Offers Revolutionary Anti-aging Hormone Therapy in Hollywood Area 2Health News:New Research Study Finds Vaccine Stops Mesothelioma in Lab Mice, According to Surviving Mesothelioma Website 2Health News:National Association of Hispanic Nurses (NAHN) Receives Five-Year Federal Grant from the National Institutes of Health (NIH) 2Health News:National Association of Hispanic Nurses (NAHN) Receives Five-Year Federal Grant from the National Institutes of Health (NIH) 3
... Office of Naval Research are working on using virtual ... Disorder (PTSD). //, ,In this research, scientists are ... from PTSD to go through the similar experiences they ... the traumatic experience that had left them unable to ...
... the declining numbers of infants in the Middle East ... first six months of their lives.//, ,"Several high-income ... Qatar, Oman, the UAE and Saudi Arabia maintain patterns ... below 35 percent," Unicef said in a statement released ...
... very active leisure time can reduce the chances of having ... from National Public Health Institute in Helsinki, Finland, had reported ... Heart Association., ,Researchers had looked into the data provided ... 25 to 64 years, all of them healthy and without ...
... the University of Arkansas, Worcester Polytechnic Institute //and other ... to examine the fossils of our ancestors’ teeth to ... and why. ,By comparing teeth from two species ... researchers confirm previous evidence that A. africanus ate more ...
... change in the genetic constitution is what makes each ... is unraveled, then health care can be individualized according ... same genetic code, how those genes express themselves at ... medicines and dietary advice. According to a recent study, ...
... Nebraska, was slated for a slow but sure death, weighing in ... or even turn over in bed. , ,Deuel is now ... than 200 kg after undergoing an operation that is becoming increasingly ... opera singer, Deborah Voigt, also lost 50 kg after she underwent ...
Cached Medicine News:Health News:Breastfeeding Decline In Middle East Worries UN 2Health News:Physical Activity During Leisure Can Reduce Risk Of Stroke 2Health News:Scientists Develop New Technology To Find About Human Ancestors’ Teet 2Health News:Learning Just How Different We Are 2Health News:Obesity better handled with gastric bypass surgery 2
S-ROM acetabular cups provide a variety of geometrical options to help address many anatomical situations and defects....
... acetabular cup system has been designed to ... tri-spiked and cluster hole configurations. The objective ... micromotion on three primary modes: Tilt, migration ... features result in initial and long-term fixation. ...
The Biopro All Poly cup is a uniquely designed UHMWPE acetabular cup....
The Plasmacup SC satisfies two important requirements: high primary stability and a low friction bearing surface....
Medicine Products: